Cardiac Resynchronization Therapy (CRT) Market share is projected to reach USD 10.94 Billion by 2030, growing at a CAGR of 7%: Straits Research

New York, United States, June 21, 2022 (GLOBE NEWSWIRE) -- Cardiac resynchronization therapy is a treatment that assists patients with arrhythmias and other disease-related abnormalities restore their heartbeat. It is especially valuable for those who have heart failure since their left and right heart segments do not pump together. The major reason for the market growth is rapid technological advancement.

The copyright of this article belongs to the original author/organization.

The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global